Motivation Predicting drug sensitivity across diverse cancer samples is a fundamental challenge in personalized therapy and drug discovery. This task requires comprehensive charact
Understanding non-genetic determinants of cell fate is critical for developing and improving cancer therapies, as genetically identical cells can exhibit divergent outcomes under t
Cancers exhibit a remarkable ability to develop resistance to a range of treatments, often resulting in relapse following first-line therapies and significantly worse outcomes for
This is a mechanistic study using computational and functional approaches to characterize a non-coding RNA's role in cancer, raising questions about therapeutic potential rather than testing clinical efficacy or providing definitive evidence of practice-changing utility.